Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPPIRE: Aspirin for Preeclampsia Prevention
NCT04402385Phase 2Terminated
- Sponsor
- Yale University
- Start
- Aug 2020
- Primary completion
- Jun 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in preeclampsia, gestational hypertension (GH), eclampsia, HELLP syndrome (HELLP), sponsored by Yale University. Started Aug 2020; status: terminated.
02
Drugs
aspirin
03
Conditions
preeclampsiagestational hypertension (GH)eclampsiaHELLP syndrome (HELLP)
Beyond the preview
Go deeper on NCT04402385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04402385.